搜索临床试验以:2.0% Mepivacaine 1:100.000 epinephrine
总计997个结果
-
Ascletis Pharmaceuticals Co., Ltd.招聘中
-
Institut Mutualiste MontsourisFondation Ophtalmologique Adolphe de Rothschild招聘中
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)完全的
-
Clarus Therapeutics, Inc.Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center完全的
-
Samuel Lunenfeld Research Institute, Mount Sinai...招聘中
-
Tampere UniversityFinnish Cultural Foundation; Sigrid Jusélius Foundation; Päivikki and Sakari Sohlberg Foundation... 和其他合作者招聘中
-
New Lexington ClinicSt. Joseph's Health Care London完全的
-
ViiV HealthcareGlaxoSmithKline完全的
-
NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences...完全的
-
University Hospital OlomoucPalacky University完全的
-
Francois LamontagneCanadian Institutes of Health Research (CIHR); Fonds de la Recherche en Santé du Québec; Canadian...完全的
-
University of Minnesota完全的
-
Washington University School of MedicineNational Cancer Institute (NCI)完全的
-
University of Sao Paulo General Hospital完全的
-
Stichting Hemato-Oncologie voor Volwassenen NederlandEuropean Myeloma Network; Gruppo Italiano Malattie EMatologiche dell'Adulto; DSMM (Deutsche Studiengruppe... 和其他合作者主动,不招人多发性骨髓瘤瑞典, 挪威, 意大利, 荷兰, 比利时, 瑞士, 澳大利亚, 丹麦, 芬兰, 捷克语, 火鸡, 奥地利, 卢森堡, 匈牙利, 希腊, 葡萄牙